ACARIZAX 12 SQ-HDM, lyophilizate sublingual 30 oral lyophilisates
Active ingredients: EXTRAIT ALLERGÉNIQUE DE DERMATOPHAGOIDES FARINAE, EXTRAIT ALLERGÉNIQUE DE DERMATOPHAGOIDES PTERONYSSINUS
Commercialized according to BDPMDispensing in France: Prescription only
Lyophilizate30 oral lyophilisatessublinguale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ACARIZAX 12 SQ-HDM, lyophilisat sublingual
- Pharmaceutical form
- lyophilisat
- Route of administration
- sublinguale
- Presentation description
- 3 plaquette(s) aluminium de 10 lyophilisat(s)
- Marketing authorisation holder
- ALK ABELLO (DANEMARK)
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Feb 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67813445CIP73004534CIP133400930045343Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| EXTRAIT ALLERGÉNIQUE DE DERMATOPHAGOIDES PTERONYSSINUSlyophilisat | 6 SQ-HDM · un lyophilisat | SA |
| EXTRAIT ALLERGÉNIQUE DE DERMATOPHAGOIDES FARINAElyophilisat | 6 SQ-HDM · un lyophilisat | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.